Results 261 to 270 of about 3,116,614 (307)

ANGPTL3 overcomes sorafenib resistance via suppression of SNAI1 and CPT1A in liver cancer. [PDF]

Transl Oncol
Lin YH, Chen CY, Chi HC, Wu MH, Lai MW, Yeh CT.   +5 more
europepmc   +1 more source

The Emerging Role of Long Noncoding RNAs in Sorafenib Resistance Within Hepatocellular Carcinoma. [PDF]

Cancers (Basel)
Vij P, Hussain MS, Satapathy SK, Cobos E, Tripathi MK.   +4 more
europepmc   +1 more source

Correction: Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1. [PDF]

BMC Cancer
Zhao J, Lin E, Bai Z, Jia Y, Wang B, Dai Y, Zhuo W, Zeng G, Liu X, Cai C, Li P, Zou B, Li J.   +12 more
europepmc   +1 more source

CSF3R-AS promotes hepatocellular carcinoma progression and sorafenib resistance through the CSF3R/JAK2/STAT3 positive feedback loop. [PDF]

Cell Death Dis
Feng Z, Gao Y, Cai C, Tan J, Liu P, Chen Y, Deng G, Ouyang Y, Liu X, Cao K, Zeng S, Han Y, Deng X, Shen H.   +13 more
europepmc   +1 more source

NOTCH1 regulates the DNA damage response and sorafenib resistance by activating ATM in hepatocellular carcinoma. [PDF]

Am J Transl Res
Liu J, Yu Y, Xu B, Liang Q, Fang T, Zhou N, Sun G.   +6 more
europepmc   +1 more source

Retraction Note: The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. [PDF]

Cell Death Dis
Zhang Z, Tan X, Luo J, Yao H, Si Z, Tong JS.   +5 more
europepmc   +1 more source

Detection and screening of small molecule agents for overcoming Sorafenib resistance of hepatocellular carcinoma: a bioinformatics study.

, 2015
Jinli Lv, Bo Zhu, Liang Zhang, Qichao Xie, Wenlei Zhuo   +4 more
openalex   +1 more source

Emodin reverses sorafenib resistance in hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition via the Akt signaling pathway. [PDF]

Transl Cancer Res
Wang Q, Zhang J.
europepmc   +1 more source

MARK1 suppress malignant progression of hepatocellular carcinoma and improves sorafenib resistance through negatively regulating POTEE. [PDF]

Open Med (Wars)
Lu X, Chen Z, Mi W, Zheng J, Liu Y.
europepmc   +1 more source

Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis. [PDF]

Immunotargets Ther
Jing F, Shi Y, Jiang D, Li X, Sun J, Guo Q.   +5 more
europepmc   +1 more source